Warren Jaworowicz

Assoc. VP of CMC at TScan Therapeutics


Office Hours

How does this work?
Ask me about
cell banks
Work experience

Mar 2020 - Present

TScan Therapeutics

Assoc. VP of CMC


Jan 2018 - Mar 2020

Editas Medicine

Sr. Director of Tecnhical Operations


Mar 2017 - Jan 2018

Editas Medicine

Director Of Technical Operations


Apr 2015 - Jan 2017


Dir. of Technical Services

Established Process Development, CMC, Outsourced Manufacturing, and Controlled Applications functions supporting global, commercial cell processing operations and pipeline programs focused on autologous cell therapies. •Hired and integrated new staff; grew team from 2 in 2015 to 12 in 2016. •Developed plans for automating production to improve quality, increase throughput, and reduce costs •Created a CMC Team structure to manage and develop pipeline and commercial programs •Created a Tech Transfer Team structure to manged outsourced manufacturing •Revamped the PMO, introducing flexible but formal project charters and project management processes •Selected and managed outsourced manufacturing partners supporting antibody production, antibody conjugation, custom media production, custom buffer production, and autologous cell therapy manufacturing. •Built specifications and metrology processes supporting global operations

Jan 2014 - Apr 2015

Shire Pharmaceuticals

Director Clinical Drug Product Manufacturing Sciences / CMC Team Lead

• Lead matrixed, cross-functional CMC teams. Ensured alignment with stakeholders and line functions, communicated progress and issues to senior management governance bodies. Provided both technical and program management leadership. • Led Clinical Drug Product Manufacturing Science group responsible for support Shire's clinical stage biologics portfolio • Managed stability operations group responsible for clinical stage stability operations.

Talk to Warren

@ Copyright 2020 OfficeHours Technologies Co.